GlassScriptPhysician profile
Brannan Danielle Malicoat
NPI 1851863252
$1,321.40
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.82 · 2022: $829 · 2023: $452 · 2024: $26.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $478.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $154.59 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $137.23 | 2023 | Gemtesa, Orgovyx |
| Antares Pharma, INC. | $128.28 | 2022-2023 | Tlando, Xyosted, Nocdurna |
| Janssen Biotech, INC. | $119.18 | 2022-2023 | Erleada |
| Urogen Pharma, INC. | $113.67 | 2022-2023 | Jelmyto |
| Bayer Healthcare Pharmaceuticals INC. | $103.83 | 2022-2023 | |
| Rochester Medical Corporation | $99.14 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $66.13 | 2022 | |
| Pfizer INC. | $65.07 | 2022-2023 | |
| Urovant Sciences INC | $57.10 | 2022 | |
| Astellas Pharma US INC | $56.60 | 2022 | |
| Hollister Incorporated | $44.33 | 2022 | |
| Accord Healthcare, INC. | $27.18 | 2022-2023 | |
| Smith+Nephew, INC. | $26.21 | 2024 | Renasys Touch, Pico, Acticoat 4" X 4" |
| Axonics, INC. | $23.22 | 2023 | Axonics |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $21.35 | 2023 | |
| Endo Pharmaceuticals INC. | $19.35 | 2022 | |
| Genzyme Corporation | $16.11 | 2022 | |
| Koelis INC. | $15.86 | 2023 | |
| Merck Sharp & Dohme LLC | $13.82 | 2021 | |
| Mission Pharmacal Company | $13.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brannan Malicoat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.